tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market
Advertisement

Tvardi Therapeutics (TVRD) Technical Analysis

Compare
2,526 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Tvardi Therapeutics’s (TVRD) Moving Averages Convergence Divergence (MACD) indicator is -6.36, suggesting Tvardi Therapeutics is a Buy.
Tvardi Therapeutics’s (TVRD) 20-Day exponential moving average is 25.65, while Tvardi Therapeutics’s (TVRD) share price is $6.58, making it a Sell.
Tvardi Therapeutics’s (TVRD) 50-Day exponential moving average is 28.80, while Tvardi Therapeutics’s (TVRD) share price is $6.58, making it a Sell.

Tvardi Therapeutics (TVRD) Pivot Points

Oct 18, 2025, 04:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.23
5.78
6.13
6.68
7.03
7.58
7.93
Fibonacci
5.78
6.12
6.34
6.68
7.02
7.24
7.58
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tvardi Therapeutics (TVRD) Moving Averages

Oct 18, 2025, 04:12 PM
Period
Simple
Exponential
MA5
6.68Sell
11.15Sell
MA10
23.83Sell
18.84Sell
MA20
30.73Sell
25.65Sell
MA50
30.10Sell
28.80Sell
MA100
27.84Sell
27.43Sell
MA200
22.83Sell
22.82Sell
Tvardi Therapeutics’s (TVRD) 10-Day exponential moving average is 18.84, while Tvardi Therapeutics’s (TVRD) share price is $6.58, making it a Sell.
Tvardi Therapeutics’s (TVRD) 100-Day exponential moving average is 27.43, while Tvardi Therapeutics’s (TVRD) share price is $6.58, making it a Sell.
Tvardi Therapeutics’s (TVRD) stock price is $6.58 and Tvardi Therapeutics’s (TVRD) 50-day simple moving average is 30.10, creating a Sell signal.
Tvardi Therapeutics’s (TVRD) stock price is $6.58 and Tvardi Therapeutics’s (TVRD) 100-day simple moving average is 27.84, creating a Sell signal.
Tvardi Therapeutics’s (TVRD) stock price is $6.58 and Tvardi Therapeutics’s (TVRD) 200-day simple moving average is 22.83, creating a Sell signal.

Tvardi Therapeutics (TVRD) Technical Indicators

Oct 18, 2025, 04:12 PM
Name
Value
Implied Action
RSI (14)
19.85
Buy
STOCH (9,6)
2.41
Buy
STOCHRSI (14)
2.41
Buy
MACD (12,26)
-6.36
Buy
ADX (14)
47.14
Neutral
Williams %R
-97.55
Buy
CCI (14)
-134.23
Buy
ATR (14)
3.97
-
Ultimate Oscillator
20.71
Sell
ROC
-82.17
Sell
Tvardi Therapeutics’s (TVRD) Relative Strength Index (RSI) is 19.85, creating a Buy signal.
Tvardi Therapeutics’s (TVRD) Trend Strength Indicator (ADX) is 47.14, creating a Neutral signal.
Tvardi Therapeutics’s (TVRD) Commodity Channel Index (CCI) is -134.23, creating a Buy signal.
Tvardi Therapeutics’s (TVRD) Price Rate of Change (ROC) is -82.17, creating a Sell signal.

FAQ

Is TVRD a Buy, Hold, or Sell?
Based on TVRD’s technical indicators, TVRD is a Sell.
    What is TVRD’s RSI (14)?
    TVRD’s RSI (14) is 19.85, which suggests TVRD is a Buy.
      What is TVRD’s MACD?
      TVRD’s MACD is -6.36, which suggests TVRD is a Buy.
        What is TVRD’s 5-day moving average?
        TVRD’s 5-day moving average is 6.68, which suggests TVRD is a Sell.
          What is TVRD’s 20-day moving average?
          TVRD 20-day moving average is 30.73, which suggests TVRD is a Sell.
            What is TVRD’s 50-day moving average?
            TVRD’s 50-day moving average is 30.10, which suggests TVRD is a Sell.
              What is TVRD’s 200-day moving average?
              TVRD’s 200-day moving average is 22.83, which suggests TVRD is a Sell.
                What is TVRD’s Williams % R (14)?
                TVRD’s Williams % R (14) is -97.55, which suggests TVRD is a Buy.
                  What is TVRD’s CCI (14)?
                  TVRD’s CCI (14) is -134.23, which suggests TVRD is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis